US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 738.000
  • -6.500-0.87%
Close Nov 22 16:00 ET
  • 738.000
  • 0.0000.00%
Post 20:01 ET
81.10BMarket Cap18.25P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-1.18%9.8B
9.87%9.81B
17.41%10.52B
40.07%10.84B
40.07%10.84B
41.19%9.91B
17.99%8.93B
27.08%8.96B
35.96%7.74B
35.96%7.74B
-Cash and cash equivalents
-6.53%2.01B
-0.85%1.92B
-33.56%2.6B
-12.10%2.73B
-12.10%2.73B
-38.35%2.15B
-42.94%1.94B
17.05%3.92B
7.63%3.11B
7.63%3.11B
-Short-term investments
0.30%7.78B
12.84%7.89B
56.99%7.92B
75.02%8.11B
75.02%8.11B
119.84%7.76B
67.59%6.99B
36.13%5.04B
65.05%4.64B
65.05%4.64B
Receivables
9.36%6.11B
11.63%5.72B
2.02%5.22B
6.35%5.67B
6.35%5.67B
0.65%5.58B
-0.78%5.12B
5.78%5.12B
-11.73%5.33B
-11.73%5.33B
-Accounts receivable
9.36%6.11B
11.63%5.72B
2.02%5.22B
6.35%5.67B
6.35%5.67B
0.65%5.58B
-0.78%5.12B
5.78%5.12B
-11.73%5.33B
-11.73%5.33B
Inventory
17.80%3.02B
14.59%2.87B
11.97%2.71B
7.44%2.58B
7.44%2.58B
6.21%2.56B
13.04%2.51B
21.75%2.42B
23.09%2.4B
23.09%2.4B
Restricted cash
----
----
----
----
----
----
--5.5M
----
----
----
Other current assets
-28.31%412M
89.00%681.9M
2.14%414.9M
-5.98%386.6M
-5.98%386.6M
28.74%574.7M
-38.18%360.8M
-4.40%406.2M
23.71%411.2M
23.71%411.2M
Total current assets
3.75%19.33B
12.76%19.08B
11.60%18.87B
22.63%19.48B
22.63%19.48B
20.78%18.63B
8.97%16.92B
18.20%16.91B
13.34%15.88B
13.34%15.88B
Non current assets
Net PPE
10.81%4.44B
9.77%4.31B
8.88%4.23B
10.19%4.15B
10.19%4.15B
8.15%4.01B
7.83%3.92B
9.12%3.88B
8.06%3.76B
8.06%3.76B
-Gross PPE
----
----
----
12.76%6.13B
12.76%6.13B
----
----
----
11.31%5.43B
11.31%5.43B
-Accumulated depreciation
----
----
----
-18.55%-1.98B
-18.55%-1.98B
----
----
----
-19.39%-1.67B
-19.39%-1.67B
Goodwill and other intangible assets
10.12%1.12B
15.66%1.1B
14.00%1.06B
13.45%1.04B
13.45%1.04B
26.50%1.02B
--953M
--928.7M
13,564.18%915.5M
13,564.18%915.5M
-Other intangible assets
----
----
----
13.45%1.04B
13.45%1.04B
----
----
----
--915.5M
--915.5M
Investments and advances
46.94%8.49B
22.05%7.72B
15.04%6.98B
-18.13%5.4B
-18.13%5.4B
-3.19%5.78B
-1.38%6.33B
-14.36%6.07B
-3.60%6.59B
-3.60%6.59B
Non current deferred assets
30.14%3.02B
34.72%2.88B
43.64%2.76B
49.41%2.58B
49.41%2.58B
59.55%2.32B
58.13%2.14B
68.81%1.92B
96.57%1.72B
96.57%1.72B
Other non current assets
154.45%1.04B
152.75%993.8M
34.50%470.2M
32.02%444.1M
32.02%444.1M
28.01%409.9M
45.68%393.2M
33.44%349.6M
55.67%336.4M
55.67%336.4M
Total non current assets
33.85%18.11B
23.81%17.01B
17.85%15.5B
2.03%13.6B
2.03%13.6B
10.44%13.53B
17.63%13.73B
9.20%13.15B
16.73%13.33B
16.73%13.33B
Total assets
16.41%37.44B
17.71%36.09B
14.34%34.37B
13.23%33.08B
13.23%33.08B
16.21%32.16B
12.69%30.66B
14.08%30.06B
14.86%29.21B
14.86%29.21B
Liabilities
Current liabilities
Payables
-7.32%497.3M
2.63%561.7M
11.98%671.3M
2.95%606.6M
2.95%606.6M
0.19%536.6M
2.45%547.3M
27.47%599.5M
-49.97%589.2M
-49.97%589.2M
-accounts payable
-7.32%497.3M
2.63%561.7M
11.98%671.3M
2.95%606.6M
2.95%606.6M
0.19%536.6M
2.45%547.3M
27.47%599.5M
4.47%589.2M
4.47%589.2M
Current accrued expenses
-4.09%2.54B
8.50%2.36B
15.36%2.39B
13.68%2.36B
13.68%2.36B
47.22%2.64B
12.55%2.18B
1.38%2.07B
30.20%2.07B
30.20%2.07B
Current deferred liabilities
50.30%627.2M
53.77%586M
21.21%516.7M
-3.98%458.9M
-3.98%458.9M
-23.74%417.3M
-32.70%381.1M
-13.23%426.3M
8.12%477.9M
8.12%477.9M
Current liabilities
1.73%3.66B
13.02%3.51B
15.51%3.58B
8.98%3.42B
8.98%3.42B
24.99%3.6B
2.32%3.1B
3.08%3.1B
-20.12%3.14B
-20.12%3.14B
Non current liabilities
Long term debt and capital lease obligation
0.05%2.7B
0.05%2.7B
0.06%2.7B
0.06%2.7B
0.06%2.7B
0.06%2.7B
0.06%2.7B
0.05%2.7B
36.43%2.7B
36.43%2.7B
-Long term debt
0.07%1.98B
0.07%1.98B
0.08%1.98B
0.08%1.98B
0.08%1.98B
0.08%1.98B
0.08%1.98B
0.07%1.98B
0.07%1.98B
0.07%1.98B
-Long term capital lease obligation
0.00%720M
0.00%720M
0.00%720M
0.00%720M
0.00%720M
0.00%720M
0.00%720M
0.00%720M
--720M
--720M
Non current deferred liabilities
65.52%207.4M
76.94%205.6M
117.31%185.8M
81.52%126.7M
81.52%126.7M
108.49%125.3M
97.96%116.2M
155.22%85.5M
-4.77%69.8M
-4.77%69.8M
Other non current liabilities
85.44%1.54B
104.13%1.46B
34.14%908.5M
33.87%854.1M
33.87%854.1M
39.06%832.4M
-1.09%716.8M
-2.19%677.3M
-6.20%638M
-6.20%638M
Total non current liabilities
21.71%4.46B
23.68%4.37B
9.61%3.8B
8.05%3.68B
8.05%3.68B
8.94%3.66B
1.47%3.54B
1.11%3.46B
24.72%3.41B
24.72%3.41B
Total liabilities
11.81%8.12B
18.70%7.88B
12.40%7.38B
8.50%7.11B
8.50%7.11B
16.35%7.26B
1.87%6.64B
2.03%6.56B
-1.73%6.55B
-1.73%6.55B
Shareholders'equity
Share capital
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
-common stock
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
17.83%30.76B
17.22%29.41B
15.99%27.98B
16.96%27.26B
16.96%27.26B
18.05%26.1B
20.67%25.09B
20.97%24.12B
22.87%23.31B
22.87%23.31B
Paid-in capital
12.90%12.7B
13.12%12.32B
12.69%11.94B
14.12%11.35B
14.12%11.35B
18.21%11.25B
19.39%10.89B
21.06%10.6B
23.02%9.95B
23.02%9.95B
Less: Treasury stock
15.66%14.19B
14.36%13.46B
16.40%12.86B
21.32%12.56B
21.32%12.56B
23.78%12.27B
30.69%11.77B
28.27%11.05B
25.33%10.35B
25.33%10.35B
Gains losses not affecting retained earnings
134.05%60.2M
64.64%-69.9M
57.49%-77.2M
66.12%-80.9M
66.12%-80.9M
35.73%-176.8M
11.66%-197.7M
-6.76%-181.6M
-811.45%-238.8M
-811.45%-238.8M
Total stockholders'equity
17.75%29.33B
17.44%28.21B
14.88%26.99B
14.60%25.97B
14.60%25.97B
16.17%24.9B
16.10%24.02B
17.98%23.5B
20.75%22.66B
20.75%22.66B
Total equity
17.75%29.33B
17.44%28.21B
14.88%26.99B
14.60%25.97B
14.60%25.97B
16.17%24.9B
16.10%24.02B
17.98%23.5B
20.75%22.66B
20.75%22.66B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -1.18%9.8B9.87%9.81B17.41%10.52B40.07%10.84B40.07%10.84B41.19%9.91B17.99%8.93B27.08%8.96B35.96%7.74B35.96%7.74B
-Cash and cash equivalents -6.53%2.01B-0.85%1.92B-33.56%2.6B-12.10%2.73B-12.10%2.73B-38.35%2.15B-42.94%1.94B17.05%3.92B7.63%3.11B7.63%3.11B
-Short-term investments 0.30%7.78B12.84%7.89B56.99%7.92B75.02%8.11B75.02%8.11B119.84%7.76B67.59%6.99B36.13%5.04B65.05%4.64B65.05%4.64B
Receivables 9.36%6.11B11.63%5.72B2.02%5.22B6.35%5.67B6.35%5.67B0.65%5.58B-0.78%5.12B5.78%5.12B-11.73%5.33B-11.73%5.33B
-Accounts receivable 9.36%6.11B11.63%5.72B2.02%5.22B6.35%5.67B6.35%5.67B0.65%5.58B-0.78%5.12B5.78%5.12B-11.73%5.33B-11.73%5.33B
Inventory 17.80%3.02B14.59%2.87B11.97%2.71B7.44%2.58B7.44%2.58B6.21%2.56B13.04%2.51B21.75%2.42B23.09%2.4B23.09%2.4B
Restricted cash --------------------------5.5M------------
Other current assets -28.31%412M89.00%681.9M2.14%414.9M-5.98%386.6M-5.98%386.6M28.74%574.7M-38.18%360.8M-4.40%406.2M23.71%411.2M23.71%411.2M
Total current assets 3.75%19.33B12.76%19.08B11.60%18.87B22.63%19.48B22.63%19.48B20.78%18.63B8.97%16.92B18.20%16.91B13.34%15.88B13.34%15.88B
Non current assets
Net PPE 10.81%4.44B9.77%4.31B8.88%4.23B10.19%4.15B10.19%4.15B8.15%4.01B7.83%3.92B9.12%3.88B8.06%3.76B8.06%3.76B
-Gross PPE ------------12.76%6.13B12.76%6.13B------------11.31%5.43B11.31%5.43B
-Accumulated depreciation -------------18.55%-1.98B-18.55%-1.98B-------------19.39%-1.67B-19.39%-1.67B
Goodwill and other intangible assets 10.12%1.12B15.66%1.1B14.00%1.06B13.45%1.04B13.45%1.04B26.50%1.02B--953M--928.7M13,564.18%915.5M13,564.18%915.5M
-Other intangible assets ------------13.45%1.04B13.45%1.04B--------------915.5M--915.5M
Investments and advances 46.94%8.49B22.05%7.72B15.04%6.98B-18.13%5.4B-18.13%5.4B-3.19%5.78B-1.38%6.33B-14.36%6.07B-3.60%6.59B-3.60%6.59B
Non current deferred assets 30.14%3.02B34.72%2.88B43.64%2.76B49.41%2.58B49.41%2.58B59.55%2.32B58.13%2.14B68.81%1.92B96.57%1.72B96.57%1.72B
Other non current assets 154.45%1.04B152.75%993.8M34.50%470.2M32.02%444.1M32.02%444.1M28.01%409.9M45.68%393.2M33.44%349.6M55.67%336.4M55.67%336.4M
Total non current assets 33.85%18.11B23.81%17.01B17.85%15.5B2.03%13.6B2.03%13.6B10.44%13.53B17.63%13.73B9.20%13.15B16.73%13.33B16.73%13.33B
Total assets 16.41%37.44B17.71%36.09B14.34%34.37B13.23%33.08B13.23%33.08B16.21%32.16B12.69%30.66B14.08%30.06B14.86%29.21B14.86%29.21B
Liabilities
Current liabilities
Payables -7.32%497.3M2.63%561.7M11.98%671.3M2.95%606.6M2.95%606.6M0.19%536.6M2.45%547.3M27.47%599.5M-49.97%589.2M-49.97%589.2M
-accounts payable -7.32%497.3M2.63%561.7M11.98%671.3M2.95%606.6M2.95%606.6M0.19%536.6M2.45%547.3M27.47%599.5M4.47%589.2M4.47%589.2M
Current accrued expenses -4.09%2.54B8.50%2.36B15.36%2.39B13.68%2.36B13.68%2.36B47.22%2.64B12.55%2.18B1.38%2.07B30.20%2.07B30.20%2.07B
Current deferred liabilities 50.30%627.2M53.77%586M21.21%516.7M-3.98%458.9M-3.98%458.9M-23.74%417.3M-32.70%381.1M-13.23%426.3M8.12%477.9M8.12%477.9M
Current liabilities 1.73%3.66B13.02%3.51B15.51%3.58B8.98%3.42B8.98%3.42B24.99%3.6B2.32%3.1B3.08%3.1B-20.12%3.14B-20.12%3.14B
Non current liabilities
Long term debt and capital lease obligation 0.05%2.7B0.05%2.7B0.06%2.7B0.06%2.7B0.06%2.7B0.06%2.7B0.06%2.7B0.05%2.7B36.43%2.7B36.43%2.7B
-Long term debt 0.07%1.98B0.07%1.98B0.08%1.98B0.08%1.98B0.08%1.98B0.08%1.98B0.08%1.98B0.07%1.98B0.07%1.98B0.07%1.98B
-Long term capital lease obligation 0.00%720M0.00%720M0.00%720M0.00%720M0.00%720M0.00%720M0.00%720M0.00%720M--720M--720M
Non current deferred liabilities 65.52%207.4M76.94%205.6M117.31%185.8M81.52%126.7M81.52%126.7M108.49%125.3M97.96%116.2M155.22%85.5M-4.77%69.8M-4.77%69.8M
Other non current liabilities 85.44%1.54B104.13%1.46B34.14%908.5M33.87%854.1M33.87%854.1M39.06%832.4M-1.09%716.8M-2.19%677.3M-6.20%638M-6.20%638M
Total non current liabilities 21.71%4.46B23.68%4.37B9.61%3.8B8.05%3.68B8.05%3.68B8.94%3.66B1.47%3.54B1.11%3.46B24.72%3.41B24.72%3.41B
Total liabilities 11.81%8.12B18.70%7.88B12.40%7.38B8.50%7.11B8.50%7.11B16.35%7.26B1.87%6.64B2.03%6.56B-1.73%6.55B-1.73%6.55B
Shareholders'equity
Share capital 0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K
-common stock 0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings 17.83%30.76B17.22%29.41B15.99%27.98B16.96%27.26B16.96%27.26B18.05%26.1B20.67%25.09B20.97%24.12B22.87%23.31B22.87%23.31B
Paid-in capital 12.90%12.7B13.12%12.32B12.69%11.94B14.12%11.35B14.12%11.35B18.21%11.25B19.39%10.89B21.06%10.6B23.02%9.95B23.02%9.95B
Less: Treasury stock 15.66%14.19B14.36%13.46B16.40%12.86B21.32%12.56B21.32%12.56B23.78%12.27B30.69%11.77B28.27%11.05B25.33%10.35B25.33%10.35B
Gains losses not affecting retained earnings 134.05%60.2M64.64%-69.9M57.49%-77.2M66.12%-80.9M66.12%-80.9M35.73%-176.8M11.66%-197.7M-6.76%-181.6M-811.45%-238.8M-811.45%-238.8M
Total stockholders'equity 17.75%29.33B17.44%28.21B14.88%26.99B14.60%25.97B14.60%25.97B16.17%24.9B16.10%24.02B17.98%23.5B20.75%22.66B20.75%22.66B
Total equity 17.75%29.33B17.44%28.21B14.88%26.99B14.60%25.97B14.60%25.97B16.17%24.9B16.10%24.02B17.98%23.5B20.75%22.66B20.75%22.66B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Infectious Disease
Infectious Disease
Intraday+0.43%